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Figure S1. Morphological changes of H. neptunium over the course of multiple cell cycles. Swarmer cells were immobilized in a 
microfluidic flow cell and followed by time-lapse DIC microscopy at 15-min intervals. The lengths and widths of the (mother) 
cell bodies were measured immediately after immobilization (swarmer cell), right before the onset of bud formation (stalked 
cell), at the end of the first cell cycle immediately before the release of the mature bud (1
st
 division), and at the end of the 
fourth and eighth cell cycle. The data are shown as box plots, with the bar indicating the median, the box the interquartile 
range, and the whiskers the 5
th
 and 95
th
 percentile. Significant differences are indicated by asterisks (***; t-test, p < 10
-8
). The 
lack of significance (t-test; p > 0.05) is indicated by ”ns”. n = 31.  
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Figure S2. Morphology of  PG hydrolase mutants. The H. neptunium wild type and strains EC36 (ΔlmdA), EC53 (ΔlmdB), EC38 
(ΔlmdD), EC39 (ΔlmdE), EC90 (ΔlmdF), SR11 (ΔdacB), SR08 (ΔdacH), EC46 (ΔdacL), EC95 (ΔmltA), SR07 (ΔgplA), SR33 (ΔrlpA), 
EC21 (ΔsltA), SR20 (ΔmltB), and SR18 (ΔamiC) were grown to exponential phase and analyzed by DIC microscopy. Scale bar: 
3 µm. (B) Cell lengths of the hydrolase mutant strains. The lengths of cells grown as described in (A) were quantified and shown 
as box plots, with the bar representing the median, the boxes the interquartile range, and the whiskers the 5
th
 and 95
th
 
percentile. None of the distributions obtained for the mutant strains is significantly different from that of the wild-type strain (t-
test, p > 0.01). 
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Figure S3. Characterization of strains producing fluorescently tagged PG biosynthetic proteins. (A) Cell length analysis. The 
H. neptunium wild type and strains SR28 (dacL-mCherry), SR14 (venus-pbp2), SE161 (venus- pbp3), EC63 (mreB-mCherry
SW
), and 
EC93 (yfp-rodZ) were grown to exponential phase and imaged by DIC microscopy. The lengths of the cells were measured and 
shown in box plots, with the bar representing the median, the boxes the interquartile range, and the whiskers the 5
th
 and 95
th
 
percentile. None of the distributions is significantly different from that of the wild-type strain (t-test, p > 0.01). (B) Stability of 
the fusion proteins analyzed in this study. The H. neptunium wild type and strains SR28 (dacL-mCherry), EC70 (Pcu::Pcu-amiC-
mCherry), EC63 (mreB-mCherry
SW
), EC93 (yfp-rodZ), SE161 (venus-pbp3), and SR14 (venus-pbp2) were grown to exponential 
phase and subjected to Western blot analysis with an anti-mCherry or anti-GFP antibody (performed as described by Jung et al., 
2015). Strain EC70 was induced for 24 h with 300 µM CuSO4 before analysis. Arrows indicate the full-length fusion proteins. 
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Figure S4. Growth rates of peptidoglycan hydrolase mutants. The growth of the H. neptunium wild type and the indicated PG 
hydrolase-deficient strains EC36 (ΔlmdA), EC53 (ΔlmdB), EC38 (ΔlmdD), EC39 (ΔlmdE), EC90 (ΔlmdF), SR11 (ΔdacB), SR08 
(ΔdacH), EC46 (ΔdacL), EC95 (ΔmltA), SR20 (ΔmltB), SR33 (ΔrlpA), EC21 (ΔsltA), SR07 (ΔgplA), and SR18 (ΔamiC) was followed 
using a microplate reader. The doubling times were normalized to the value obtained for the wild-type strain (3.6 ± 0.3 h). 
 
 
 
 
Figure S5. (A) Morphology of PG synthase mutants. Cells of strains SR31 (ΔldtA), CR04 (ΔldtB), SR32 (ΔldtAB), and EC89 (ΔmtgA) 
were grown to exponential phase and analyzed by DIC microscopy. Scale bar: 3 µm. (B) Growth rates of PG synthase mutants. 
The growth of the H. neptunium wild type and the indicated PG synthase-deficient strains EC26 (Δpbp1X), EC27 (Δpbp1C), and 
EC57 (Δpbp1X Δpbp1C), SR31 (ΔldtA), CR04 (ΔldtB), SR32 (ΔldtAB), and EC89 (ΔmtgA) was followed using a microplate reader. 
The doubling times were normalized to the value obtained for the wild-type strain (3.6 ± 0.3 h). 
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Figure S6. Subcellular distribution of Venus-PBP3. Shown are demographs of swarmer and stalked cells of strain SE161 (venus-
pbp3). 
 
 
 
 
Figure S7.  Structural model of H. neptunium MreB. Structural model of H. neptunium MreB (MreBHNE; in blue), generated 
using the crystal structure of ADP-bound MreB from C. crescentus (MreBCC; PDB 4CZF; in orange) as a template. 
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Figure S8. Effect of the MreB inhibitor A22 on MreB. (A) Inhibition of H. neptunium growth by the MreB inhibitor A22. 
Exponentially growing H. neptunium wild-type cells were diluted into fresh media containing the indicated concentrations of 
A22. Subsequently, their growth was monitored for 30 h using a microplate reader. (B) Effect of A22 on cell morphology. Cells 
were grown to exponential phase and exposed for 24 h to 90 µM A22. After washing and resuspension in medium lacking the 
inhibitor, cells were cultivated further to monitor the gradual recovery of wild-type morphology. Samples were taken at the 
indicated time points after addition (+) or removal (-) of A22 and analyzed by DIC microscopy. Scale bar: 3 µm. (C,D) 
Quantitative analysis of changes in cell shape after A22 treatment. Cells were grown to exponential phase and exposed to the 
indicated concentrations of A22 for 24 h. After imaging by DIC microscopy, the lengths (C) and widths (D) of their cell bodies 
(excluding stalks and buds) were measured. The data are shown as box plots, as described in Figure S3A. Distributions 
significantly different from that of the control culture (0 µM) are indicated (***; t-test, p < 10
-3
 in C and p < 10
-12
 in D). n = 100 
for each concentration. (E) Delocalization of MreB-mCherry
SW
 in the presence of A22 or MP265. Cells of strain EC63 (mreB-
mCherry
SW
) were grown to exponential phase, exposed to A22 (35 µM) or MP265 (250 µM) for 1 h, and subjected to 
fluorescence microscopy. After determination of the fluorescence profiles of random subpopulations of cells, the data were 
plotted as demographs. Cells grown in the absence of any inhibitor are analyzed as a control. 
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Figure S9. Delocalization of PG incorporation after inhibition of MreB. Cells of the H. neptunium wild-type strain were grown 
for 5 h in the absence (control) or presence of 250 µM MP265, labeled with HADA, and analyzed by fluorescence microscopy. 
The demographs show fluorescence profiles obtained from random subpopulations of cells from each condition. 
 
SUPPLEMENTAL MOVIES 
Movie S1. Time-lapse analysis of growing H. neptunium cells. Wild-type cells were grown in a microfluidic device and imaged 
at 15 min intervals by DIC microscopy. Scale bar: 2 µm. 
 
  
8 
 
SUPPLEMENTAL TABLES 
Table S1. Proteins investigated in this work. 
Protein ORF number Predicted function 
Lytic enzymes 
Metallopeptidases 
  
LmdA HNE_0632 Peptidase (M23 family) 
LmdB HNE_0633 Peptidase (M23 family) 
LmdC HNE_2628 Peptidase (M23 family) 
LmdD HNE_2982 Peptidase (M23 family) 
LmdE HNE_3210 Peptidase (M23 family) 
LmdF HNE_3409 Peptidase (M23 family) 
Carboxypeptidases   
DacB HNE_0402 D-Ala-D-Ala carboxy-/endopeptidase 
DacH HNE_1025 D-Ala-D-Ala carboxypeptidase 
DacL HNE_1814 D-Ala-D-Ala carboxypeptidase 
Glycosyl hydrolases   
GplA HNE_0445 Glycosyl hydrolase family protein 
MltA HNE_0008 Lytic murein transglycosylase MltA 
MltB HNE_3349 Lytic murein transglycosylase 
RlpA HNE_1815 Lytic transglycosylase 
SltA HNE_2801 Lytic transglycosylase, SLT family 
Amidase   
AmiC 
 
HNE_0674 N-acetylmuramoyl-L-Ala amidase 
Synthetic enzymes   
Bifunctional PBPs   
PBP1A HNE_1911 Penicillin-binding protein 1A 
PBP1C HNE_3002 Penicillin-binding protein 1C 
PBP1X HNE_0768 Penicillin-binding protein, 1A family 
Monofunctional PBPs   
PBP2 HNE_2934 Penicillin-binding protein 2 
PBP3 HNE_3030 Penicillin-binding protein 3, FtsI 
L,D-Transpeptidases   
LdtA HNE_0929 L,D-transpeptidase 
LdtB HNE_3551 L,D-transpeptidase 
Synthetic Transglycosylase   
MtgA 
 
HNE_3102 Monosynthetic transglycosylase 
Regulatory factors   
MreB HNE_2937 Actin homologue MreB 
RodZ 
 
HNE_0620 MreB-associated protein RodZ 
 
  
9 
 
Table S2. H. neptunium strains used in this study. 
Strains Genotype/description Construction References 
LE670 Wild type (ATCC 15444) 
 
Leifson (1964) 
CR04 LE670 ΔHNE3551 (ldtB) In-frame deletion of HNE3551 in LE670 using pCR04 This study 
EC21 LE670 ΔHNE2801 (sltA) In-frame deletion of HNE2801 in LE670 using pEC28 This study 
EC26 LE670 ΔHNE0768 (pbp1X) In-frame deletion of HNE0768 in LE670 using pEC22 This study 
EC27 LE670 ΔHNE3002 (pbp1C) In-frame deletion of HNE3002 in LE670 using pEC26 This study 
EC36 LE670 ΔHNE0632 (lmdA) In-frame deletion of HNE0632 in LE670 using pEC34 This study 
EC38 LE670 ΔHNE2982 (lmdD) In-frame deletion of HNE2982 in LE670 using pEC38 This study 
EC39 LE670 ΔHNE3210 (lmdE) In-frame deletion of HNE3210 in LE670 using pEC39 This study 
EC46 LE670 ΔHNE1814 (dacL) In-frame deletion of HNE1814 in LE670 using pEC64 This study 
EC53 LE670 ΔHNE0633 (lmdB) In-frame deletion of HNE0633 in LE670 using pEC35 This study 
EC57 LE670 ΔHNE0768 (pbp1X) 
ΔHNE3002 (pbp1C) 
In-frame deletion of HNE3002 in EC26 using pEC26 This study 
EC63 LE670 mreB-mCherry
SW
 Gene replacement in LE670 using pEC87 This study 
EC70 LE670 Pcu::Pcu-HNE0674 (amiC)-
mCherry 
Integration of pEC115 in LE670 This study 
EC89 LE670 ΔHNE3102 (mtgA) In-frame deletion of HNE3102 in LE670 using pEC65 This study 
EC90 LE670 ΔHNE3409 (lmdF) In-frame deletion of HNE3409 in LE670 using pEC126 This study 
EC93 LE670 yfp-HNE0620 (rodZ) Gene replacement in LE670 using pEC129  This study 
EC95 LE670 ΔHNE0008 (mltA) In-frame deletion of HNE0008 in LE670 using pEC157 This study 
SE161 LE670 venus-HNE3030 (pbp3) Gene replacement in LE670 using pSE68  This study 
SR07 LE670 ΔHNE0445 (glpA) In-frame deletion of HNE0445 in LE670 using pSR02 This study 
SR08 LE670 ΔHNE1025 (dacH) In-frame deletion of HNE1025 in LE670 using pSR03 This study 
SR11 LE670 ΔHNE0402 (dacB) In-frame deletion of HNE0402 in LE670 using pSR01 This study 
SR14 LE670 venus-HNE2934 (pbp2) Gene replacement in LE670 using pSR06 This study 
SR18 LE670 ΔHNE0674 (amiC) In-frame deletion of HNE0674 in LE670 using pSR22 This study 
SR20 LE670 ΔHNE3349 (mltB) In-frame deletion of HNE3349 in LE670 using pSR19 This study 
SR24 LE670 HNE0633 (lmdB)-
mCherry 
Gene replacement in LE670 using pSR13 This study 
SR26 LE670 HNE3409 (lmdF)-mCherry Gene replacement in LE670 using pSR17 This study 
SR28 LE670 HNE1814 (dacL)-mCherry Gene replacement in LE670 using pSR38 This study 
SR31 LE670 ΔHNE0929 (ldtA) In-frame deletion of HNE0929 in LE670 using pEC174 This study 
SR32 LE670 ΔHNE0929 (ldtA) 
ΔHNE3551 (ldtB) 
In-frame deletion of HNE0929 in CR04 using pEC174 This study 
SR33 
 
LE670 ΔHNE1815 (rlpA) In-frame deletion of HNE1815 in LE670 using pEC172 This study 
 
Table S3. E. coli strains used in this study. 
Strains Genotype/description References 
TOP10 F
–
 mcrA Δ(mrr-hsdRMS-mcrBC) Φ80lacZΔM15 ΔlacX74 recA1 araD139 Δ(ara leu) 7697 galU galK 
rpsL (Str
R
) endA1 nupG 
Invitrogen 
WM6034 thrB1004 pro thi rpsL hsdS lacZΔM15 RP4–1360 Δ(araBAD)567 ΔdapA1341::[erm pir(wt)] W. Metcalf  
(unpublished) 
   
 
Table S4. General plasmids used in this work. 
Plasmids Description References 
   
pCCHYC-2 Integrating plasmid to construct C-terminal fusions to mCherry under the control of Pcu, 
Kan
R
 
Jung et al., 2014 
pCHYC-2 Integrating plasmid to construct C-terminal fusions to mCherry at a site of interest, Kan
R
 Thanbichler et al., 2007 
pCVENC-2 Integrating plasmid to construct C-terminal fusions to Venus under the control of  Pcu, Kan
R
 Jung et al., 2014 
pCVENN-3 Integrating plasmid to construct N-terminal fusions to Venus under the control of Pcu, Rif
R
 Jung et al., 2014 
pCYFPC-2 Integrating plasmid to construct C-terminal fusions to YFP under the control of Pcu, Kan
R
 Jung et al., 2014 
pCYFPN-2 Integrating plasmid to construct N-terminal fusions to YFP under the control of Pcu, Kan
R
 Jung et al., 2014 
pNPTS138 sacB-containing suizide vector used for double homologous recombination, Kan
R
 M.R. Alley, unpublished 
pZVENN-2 Integrating plasmid to construct N-terminal fusions to Venus under the control of Pzn, Kan
R
 Jung et al., 2014 
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Table S5. Plasmids generated in this work. 
Plasmids Description Construction 
   
pCR04 pNPTS135 derivative for 
in-frame deletion of 
HNE3551 (ldtB) 
a) amplification of the HNE3551 flanking regions from LE670 chrom. DNA using primers 
oCR16+oCR17 (upstream) and oCR18+oCR19 (downstream),  
b) restriction of the upstream fragment with HindIII and BamHI, restriction of the downstream 
fragment with BamHI and NheI 
c) triple ligation with pNPTS138 cut with PstI and NheI 
pEC115 pCCHYC-2 bearing 
HNE0674 (amiC)-
mCherry 
a) amplification of HNE_0674 from LE670 chrom. DNA using primers oEC157+SS271, restriction 
with NdeI and KnpI,  
b) ligation with pCCHYC-2 cut with NdeI and KnpI 
pEC12 pCCHYC-2 bearing 
HNE3409 (lmdF)-
mCherry 
a) amplification of HNE3409 from LE670 chrom. DNA using primers oEC23+oEC24, restriction 
with KpnI and NdeI                                                                                                      
b) ligation with pCCHYC-2 cut with KpnI and NdeI 
pEC126 pNPTS135 derivative for 
in-frame deletion of 
HNE3409 (lmdF) 
a) amplification of the HNE3409 flanking regions from LE670 chrom. DNA using primers 
oEC289+oEC290 (upstream) and oEC291+oEC292 (downstream),  
b) restriction of the upstream fragment with HindIII and BamHI, restriction of the downstream 
fragment with BamHI and NheI 
c) triple ligation with pNPTS138 cut with HindIII and NheI 
pEC129 pNPTS135 derivative for 
replacing rodZ with yfp-
rodZ (HNE0620) 
a) amplification of three fragments for extension overlap PCR  using primers  oEC244+oEC245 
(template: LE670 chrom. DNA), oEC246+oEC247 (template: pCYFPC-2),  oEC248+oEC249  
(template: LE670 chrom. DNA)                                                                                                                                          
b) fusion of the three fragments by extension-overlap PCR to generate upstream-eyfp-
HNE0620 using primers oEC244+oEC249                                                                                                                
c) restriction of upstream-eyfp-HNE0620 with HindIII and NheI and ligation with pNPTS138 cut 
with HindIII and NheI 
pEC157 pNPTS135 derivative for 
in-frame deletion of 
HNE0008 (mltA) 
a) amplification of the HNE0008 flanking regions from LE670 chrom. DNA using primers 
oEC313+oEC314 (upstream) and oEC315+oEC316 (downstream),  
b) restriction of the upstream fragment with HindIII and BamHI, restriction of the downstream 
fragment with BamHI and NheI 
c) triple ligation with pNPTS138 cut with HindIII and NheI 
pEC172 pNPTS135 derivative for 
in-frame deletion of 
HNE1815 (rlpA) 
a) amplification of the HNE1815 flanking regions from LE670 chrom. DNA using primers 
oEC326+oEC327 (upstream) 
b) amplification of the downstream region from LE670 chrom. DNA by a nested PCR using first 
primers oEC326+oE331 and then primers oEC328+oEC329 
c) restriction of the upstream flank with BamHI and HindIII, restriction of downstream flank 
with BamHI and NheI 
c) triple ligation with pNPTS138 cut with HindIII and NheI 
pEC174 pNPTS135 derivative for 
in-frame deletion of 
HNE0929 (ldtA) 
a) amplification of HNE0929 flanking regions from LE670 chrom. DNA using primers 
oEC338+oEC339 (upstream) and oEC340+oEC341 (downstream) 
b) restriction of upstream flank with BamHI and KpnI, restriction of downstream flank with 
KpnI and NheI 
c) triple ligation with pNPTS138 digested with BamHI and NheI 
pEC22 pNPTS135 derivative for 
in-frame deletion of 
HNE0768 (pbp1X) 
a) amplification of HNE0768 flanking regions from LE670 chrom. DNA using primers 
oEC33+oEC34 (upstream) and oEC35+oEC36 (downstream),  
b) restriction of upstream fragment with PstI and HindIII, restriction of the downstream 
fragment with HindIII and NheI 
c) triple ligation with pNPTS138 cut with PstI and NheI 
pEC26 pNPTS135 derivative for 
in-frame deletion of 
HNE3002 (pbp1C) 
a) amplification of the HNE3002 flanking regions from LE670 chrom. DNA using primers 
oEC49+oEC50 (upstream) and oEC51+oEC52 (downstream),  
b) restriction of the upstream fragment with EcoRI and HindIII, restriction of the downstream 
fragment with HindIII and NheI 
c) triple ligation with pNPTS138 cut with EcoRI and NheI 
pEC28 pNPTS135 derivative for 
in-frame deletion of 
HNE2801 (sltA) 
a) amplification of the HNE2801 flanking regions from LE670 chrom. DNA using primers 
oEC55+oEC56 (upstream) and oEC57+oEC58 (downstream) 
b) restriction of the upstream fragment with HindIII and NheI, restriction of downstream 
fragment with NheI and EcoRI 
c) triple ligation with pNPTS138 cut with HindIII and EcoRI 
pEC34 pNPTS135 derivative for 
in-frame deletion of 
HNE0632 (lmdA) 
a) amplification of the HNE0632 flanking regions from LE670 chrom. DNA using primers 
oEC84+oEC85 (upstream) and oEC86+oEC87 (downstream) 
b) restriction of the upstream fragment with BamHI and HindIII, restriction of the downstream 
fragment with BamHI and NheI 
c) triple ligation with pNPTS138 cut with HindIII and NheI 
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Table S5. Plasmids generated in this work (continued). 
pEC35 pNPTS135 derivative for 
in-frame deletion of 
HNE0633 (lmdB) 
a) amplification of the HNE0663 flanking regions from LE670 chrom. DNA using primers 
oEC88+oEC89 (upstream) and oEC90+oEC91 (downstream),  
b) restriction of the upstream fragment with PstI and HindIII, restriction of the downstream 
fragment with HindIII and NheI 
c) triple ligation with pNPTS138 cut with PstI and NheI 
pEC38 pNPTS135 derivative for 
in-frame deletion of 
HNE2982 (lmdD) 
a) amplification of the HNE2982 flanking regions from LE670 chrom. DNA using primers 
oEC92+oEC93 (upstream) and oEC94+oEC95 (downstream)  
b) restriction of the upstream fragment with PstI and HindIII, restriction of the downstream 
fragment with HindIII and NheI 
c) triple ligation with pNPTS138 cut with PstI and NheI 
pEC39 pNPTS135 derivative for 
in-frame deletion of 
HNE3210 (lmdE) 
a) amplification of the HNE3210 flanking regions from LE670 chrom. DNA using primers 
oEC96+oEC97 (upstream) and oEC98+oEC99 (downstream),  
b) restriction of the upstream fragment with EcoRI and HindIII, restriction of the downstream 
fragment with HindIII and NheI 
c) triple ligation with pNPTS138 cut with EcoRI and NheI 
pEC48 pCCHYN-2 bearing 
mCherry-mreB 
a) amplification of HNE_2937 from LE670 chrom. DNA using primers oEC123+oEC124, 
restriction with KpnI and NheI                                                                                                        
b) ligation with pCCHYN-2 cut with KpnI and NheI 
pEC55 pCVENN-3 bearing 
venus-HNE2934 (pbp2) 
a) amplification of HNE2934 from LE670 chrom. DNA using primers oEC9+oEC10, restriction 
with KpnI and NheI                                                                                 
b) ligation into pCCHYN-2 cut with KpnI and NheI 
pEC64 pNPTS135 derivative for 
in-frame deletion of 
HNE1814 (dacL) 
a) amplification of HNE1814 flanking regions from LE670 chrom. DNA using primers 
oEC137+oEC138 (upstream) and oEC139+oEC140 (downstream)  
b) restriction of upstream flankwith EcoRI and PstI, restriction of downstream flank with EcoRI 
and NheI 
c) triple ligation with pNPTS138 cut PstI and NheI 
pEC65 pNPTS135 derivative for 
in-frame deletion of 
HNE3102 (mtgA) 
a) amplification of the HNE3102 flanking regions from LE670 chrom. DNA using primers 
oEC295+oEC142 (upstream) and oEC143+oEC296 (downstream),  
b) restriction of the upstream fragment with HindIII and EcoRI, restriction of the downstream 
fragment with EcoRI and NheI 
c) triple ligation with pNPTS138 cut with HindIII and NheI 
pEC7 pCCHYC-2 bearing 
HNE1814 (dacL)-
mCherry 
a) amplification of HNE1814 from LE670 chrom. DNA using primers oEC27 and oEC28, 
restriction with KpnI and NdeI                                                                                              
b) ligation into  pCCHYC-2 cut with KpnI and NdeI 
pEC87 pNPTS135 derivative for 
replacing mreB with 
mreB-mCherry
SW
 
a) amplification of three fragments for extension overlap PCR  using primers  oEC182+oEC184 
(template pEC48), oEC183+oEC186  (template pCCHYC-2), oEC185+oEC124 (template pEC48)                                                                                           
b) fusion of the fragments by extension-overlap PCR to generate an mreB’-mCherry-‘mreB 
fragment using primers oEC182+oEC124                                                                                                                       
c) digestion of mreB’-mCherry-‘mreB with HindIII and NheI and ligation into pNPTS138 cut with 
HindIII and NheI  
pSE68 pNPTS138 derivative for 
replacing native ftsI 
with venus-ftsI 
(HNE3030) 
a) amplification of the upstream region of HNE3030 from ATCC15444 chrom. DNA using 
primers oSE88+oSE89                                                                                                                                                    
b) amplification of HNE3030 from LE670 chrom. DNA using primers oSE20+oSE21, restriction 
with KpnI and SacI, ligation into pZVENN-2 cut with KpnI and SacI, amplification of venus-ftsI' 
from the resulting plasmid using primers oSE90+oSE91                                 
c) fusion of the two PCR-products by overlap-extension PCR                                                                            
d) digestion with HindIII and BamHI and ligation into pNPTS138 cut with HindIII BamHI 
pSR01 pNPTS135 derivative for 
in-frame deletion of 
HNE0402 (dacB) 
a) amplification of the HNE0402 flanking regions from LE670 chrom. DNA using primers 
oSR01+oSR02 (upstream) and oSR03+oSR04 (downstream)  
b) restriction of the upstream fragment with HindIII and EcoRI, restriction of the downstream 
fragment with EcoRI and NheI 
c) triple ligation with pNPTS138 cut with HindIII and NheI 
pSR02 pNPTS135 derivative for 
in-frame deletion of 
HNE0445 (gplA) 
a) amplification of the HNE0445 flanking regions from LE670 chrom. DNA using primers 
oSR05+oSR06 (upstream) and oSR07+oSR08 (downstream)  
b) restriction of the upstream fragment with HindIII and EcoRI, restriction of the downstream 
fragment with EcoRI and NheI 
c) triple ligation with pNPTS138 cut with HindIII and NheI 
pSR03 pNPTS135 derivative for 
in-frame deletion of 
HNE1025 (dacH) 
a) amplification of the HNE1025 flanking regions from LE670 chrom. DNA using primers 
oSR9+oSR10 (upstream) and oSR11+oSR12 (downstream)  
b) restriction of the upstream fragment with HindIII and EcoRI, restriction of the downstream 
fragment with EcoRI and NheI  
c) triple ligation with pNPTS138 cut with HindIII and NheI 
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Table S5. Plasmids generated in this work (continued). 
pSR06 pNPTS138 derivative for 
replacing native 
HNE2934 with venus-
HNE2934 (pbp2) 
a) amplification of two fragments for extension overlap PCR using primers oSR32+oSR31 
(template: pEC55) and oEC48+oEC33 (template: LE670 chrom. DNA)                                                               
b) fusion of both fragments by extension-overlap PCR to generate upstream-venus-pbp2 using 
oEC48+oEC31                                                                                                                                                                       
c) restriction of upstream-venus-HNE2934 with HindIII and NheI and ligation with pNPTS138 
digested with HindIII and NheI 
pSR17 pNPTS138 derivative for 
replacing native 
HNE3409 with HNE3409 
(lmdF)-mCherry 
a) amplification of two fragments for extension overlap PCR using primers oSR70+oSR72 
(template: pEC12) and oSR71+oEC103 (template: LE670 chrom. DNA)                                                              
b) fusion of both fragments by extension overlap PCR to generate HNE3409-mCherry-
downstream using primers oSR70+oEC103                                                                                                                 
c) restriction of HNE3409-mCherry-downstream with HindIII and NheI and ligation with 
pNPTS138 digested with HindIII and NheI 
pSR19 pNPTS135 derivative for 
in-frame deletion of 
HNE3349 (mltB) 
a) amplification of two fragments for extension overlap PCR using primers oSR81+oSR84 
(template: pCVENC-2) and oSR82+oSR83 (template LE670 chrom. DNA)                                                                               
b) fusion of both fragments by extension overlap PCR to generate HNE3349-mCherry-
downstream using primers oSR81+oSR82                                                                                                                  
c) digestion of HNE3349-mCherry-downstream with HindIII and NheI and ligation with 
pNPTS138 cut with HindIII and NheI 
pSR22 pNPTS135 derivative for 
in-frame deletion of 
HNE0674 (amiC) 
a) amplification of the HNE0674 flanking regions from LE670 chrom. DNA using primers 
oSR89+oSR90 (upstream) and oSR91+oSR92 (downstream) 
b) restriction of the upstream fragment with HindIII and BamHI, restriction of the downstream 
fragment with BamHI and NheI 
c) triple ligation with pNPTS138 digested with HindIII and NheI 
pSR38 pNPTS138 derivative for 
replacing native 
HNE1814 with HNE1814 
(dacL)-mCherry 
a) amplification of two fragments for extension overlap PCR using primers oSR73+oSR76 
(template: pEC07) and oSR74+oSR75 (template: LE670 chrom. DNA)                                                                                                                       
b) fusion of both fragments by extension overlap PCR to generate HNE1814-mCherry-
downstream using primers oS73+oSR74                                                                                                                             
c) restriction of HNE1814-mCherry-downstream with HindIII and NheI and ligation with 
pNPTS138 cut with HindIII and NheI 
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Table S6. Oligonucleotides used in this work. 
ID Oligonucleotide Sequence 
1 
Restriction site 
oCR16 HNE_3551_Del1f TTTTAAGCTTGTATGGGTTGTGACGGCCGCG HindIII 
oCR17 HNE_3551_Del1r CTAGGATCCCAGTTTTCCCTCTGAAAAGGC BamHI 
oCR18 HNE_3551_Del2f GAGGGATCCCGTCTGACGGGCCGTTCGGCG BamHI 
oCR19 HNE_3551_Del2r TATAGCTAGCGCTTTCTCGCTCATCAAGATG NheI 
oEC9 HNE_2934_for AAAAGGTACCATGAGCCGGAAAAGTAAAAACGCTG KpnI 
oEC10 HNE_2934_rev TTTTGCTAGCTCATGCCGGGTCACCGGTGTTG NheI 
oEC23 HNE_3409_for AAACATATGCTGAAAAGACGCTTATCCGCC NdeI 
oEC24 HNE_3409_rev TTTGGTACCTTCGATGATCTCGTAGCCTTCGGG KpnI 
oEC27 HNE_1814_for TTTCATATGGTGTTTGCGGCCCTACTGACCCTCG NdeI 
oEC28 HNE_1814_rev ATAGGTACCGTCATTGCTGCTGGAAATAAACGTG  KpnI 
oEC33 HNE_0768_del1 TATCTGCAGCACGAAGCCCGGCATGTCCTCAT PstI 
oEC34 HNE_0768_del2 TATAAGCTTGGGTGAAGGCACCCGCTGGTATA HindIII 
oEC35 HNE_0768_del3 ATATAAGCTTCAGGCGGAATAGGCCAAAGAACAG HindIII 
oEC36 HNE_0768_del4 ATATGCTAGCGCTATGCGTGGCGATGGCGGACCT NheI 
oEC49 HNE_3002_del1 AAAGAATTCGGATCAATGCCGCGAATGAAGTGGG EcoRI 
oEC50 HNE_3002_del2 TTTAAGCTTGACCCCGCCTGACGCCCGGTCTG HindIII 
oEC51 HNE_3002_del3 TTTTAAGCTTGCGTTTCGGCACGGACTGGCCC HindIII 
oEC52 HNE_3002_del4 TTTTGCTAGCGCGCTTCCTCGGCATGGACGGC NheI 
oEC55 HNE_2801_del1 ATATAAGCTTTATAAAGCACCACGGGCAGGGCGAC HindIII 
oEC56 HNE_2801_del2 ATATGCTAGCAATCCGGAGCATGGTTCGGCT  NheI 
oEC57 HNE_2801_del3 ATATGCTAGCGGCCGCCGCTGACCGGAAGTGTC NheI 
oEC58 HNE_2801_del4 ATATGAATTCGTAAGCACGCCAATGGTCGCCGA EcoRI 
oEC84 HNE_0632_del1 TATAAGCTTGGTGTCCGAGCAGGCCCGCGAGCAT HindIII 
oEC85 HNE_0632_del2 ATAGGATCCAACTCCGCCCGGATGGCAAACGCCC BamHI 
oEC86 HNE_0632_del3 ATAGGATCCGACAGGAATCCGAGGCAGCTTTCGC BamHI 
oEC87 HNE_0632_del4 TTTTGCTAGCGACACCGCCTATGCCCACCTCTCGC NheI 
oEC88 0633_del1new TATCTGCAGGGCGCAGGCGCTGGCCCCGCGTGGG PstI 
oEC89 HNE_0633_del2 TATGAATTCCCGCGTGAAGCAACGCCCGTAAGCC EcoRI 
oEC90 HNE_0633_del3 TATGAATTCGGTTGCCGGGGCGATGGGAAGGTCG EcoRI 
oEC91 HNE_0633_del4 TTTTGCTAGCCTTCCTGGGCCTCTGCGGGCACATC NheI 
oEC92 HNE_2982_del1 TATCTGCAGTCTATCAGGAAGACGGCAAGGTTTG PstI 
oEC93 HNE_2982_del2 TATAAGCTTCCCTATGAAGGGGCGTTGCAGGCCG HindIII 
oEC94 HNE_2982_del3 TATAAGCTTGGCCGCGAGCGCAAGAGCAATCGCC HindIII 
oEC95 HNE_2982_del4 TTTTGCTAGCCATTCTTCCCAAGCCCGGCATTGAC NheI 
oEC96 HNE_3210_del1 TATGAATTCGGCCGTTGATCTCGGTGATATAGTC EcoRI 
oEC97 HNE_3210_del2 TATAAGCTTCTTAATCCTGCAGAGTGGTTGTCGC HindIII 
oEC98 HNE_3210_del3 TATAAGCTTAGGGCGGAAAAAGCGCATGCGCGGA HindIII 
oEC99 HNE_3210_del4 TTTTGCTAGCGGGCGTTGGCGTTGGGTGGCGCTTG NheI 
oEC103 HNE_3409_del4 TTTTGCTAGCTCGGTTGCGGGCGACAGCGCCGTTG NheI 
oEC123 2937_for TTTGGTACCATGATCGGTAGCCTCCTCGGCCTG KpnI 
oEC124 2937_rev TTTTGCTAGCTCAGACTTCCGGGCAGAGGACGC NheI 
oEC137 HNE_1814_del1 TATCTGCAGGCTTTTGGTCTGCGCTCGAACGTG PstI 
oEC138 HNE_1814_del2 ATATGAATTCGTTCGCACGTTTATTTCCAGCAGC EcoRI 
oEC139 HNE_1814_del3 ATATGAATTCGAGCGCTCCGAGGGTCAGTAGGGC EcoRI 
oEC140 HNE_1814_del4 TATAGCTAGCCGTGTCGGCGCCGGTTGCTGC NheI 
oEC142 HNE_3102_del2 ATATGAATTCGTAGGCGGGGGCGGAGGAGTTCATG EcoRI 
oEC143 HNE_3102_del3 ATATGAATTCCCACCGGCCCCACAGAACTCCGCC EcoRI 
oEC157 HNE_0674_for TATACATATGGGCACTCAACGCCCGTCTCATAC NdeI 
oEC182 2937_for2 TATAAGCTTATGATCGGTAGCCTCCTCGGCCTG HindIII 
oEC183 2937-SF-eol-for CCGCGATGCCGCCTGAAAGCGGATCGAGCATGGTGAGCAAGGGCGAGGAG - 
oEC184 2937-SF-eol-rev CTCCTCGCCCTTGCTCACCATGCTCGATCCGCTTTCAGGCGGCATCGCGG - 
oEC185 2937-SF-eol-for2 GGACGAGCTGTACAAGTCTGGTGCACCGGGTAACGGCACCGGCATGGCGC - 
oEC186 2937-SF-eol-rev2 GCGCCATGCCGGTGCCGTTACCCGGTGCACCAGACTTGTACAGCTCGTCC - 
oEC244 HNE_0620_eol_for TATAGCTAGCCGCGCTCGACCATAAAGGT NheI 
oEC245 HNE_0620_eol_rev TCCTCGCCCTTGCTCACCATATTCTACCAGTCACTTCGAC - 
oEC246 HNE_0620_eol_for2 GTCGAAGTGACTGGTAGAATATGGTGAGCAAGGGCGAGGA - 
oEC247 HNE_0620_eol_rev2 TGGGTCATGTTGTGTGCCATATGCATATTAATTAAGGCGC - 
oEC248 HNE_0620_eol_for3 GCGCCTTAATTAATATGCATATGGCACACAACATGACCCA - 
oEC249 HNE_0620_eol_rev3 TTTAAGCTTCGGCCAGTGTGCGGCTGAG HindIII 
oEC289 HNE_3409_del1new TTTAAGCTTCCCGGCCAGAAGGACACAAAATGAG HindIII 
oEC290 HNE_3409_del2new ATAGGATCCGGATAGTCCGATGGCGGATAAGCGT BamHI 
oEC291 HNE_3409_del3new ATAGGATCCTGGGTCATCCCCGAAGGCTACGAGA BamHI 
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Table S6. Oligonucleotides used in this work (continued). 
oEC292 HNE_3409_del4new TATAGCTAGCCGCGCTGTATATGCCGCCGGC NheI 
oEC295 HNE_3102_del1new TTTAAGCTTGGGCCGCCACACAAACCTCGTCAGC HindIII 
oEC296 HNE_3102_del4new TATAGCTAGCGCAGGCGCTCATCGAGGCTGACC NheI 
oEC313 HNE_0008_del1 TTTAAGCTTAGGATTTCGCCGCCAACATGTC HindIII 
oEC314 HNE_0008_del2 TTTGGATCCAAGGGCGGAAAACAGGAGAGCA BamHI 
oEC315 HNE_0008_del3 TTTGGATCCGTCGCCGCGCGCACGCCTGCGCC BamHI 
oEC316 HNE_0008_del4 TATAGCTAGCCAAGGACACGGCAGACGAGTAC NheI 
oEC326 HNE_1815_del1 TTTAAGCTTGAACAGTATGCGATGGAAAAT HindIII 
oEC327 HNE_1815_del2 TTTGGATCCCCGGCCAACAAAAGTCGAACG BamHI 
oEC328 HNE_1815_del3 TTTGGATCCGGCACGGCGGACGGCCGGATC BamHI 
oEC329 HNE_1815_del4 TATAGCTAGCCGTCATCTTGGCGAGCCGGGC NheI 
oEC331 1815_del_check_rev GAAGATTCCAGATGCCCCGTC - 
oEC338 HNE_0929_del1 TTTGGATCCCGCAAGCGTCAGCAGCAACAG BamHI 
oEC339 HNE_0929_del2 CGCGGTACCAAAGAGCAGAAGAAACAGGGT KpnI 
oEC340 HNE_0929_del3 CGCGGTACCGTCCCGGAAGGAACCTTCCTG KpnI 
oEC341 HNE_0929_del4 TATAGCTAGCCCGGCCTGCATATCCTCGTTG NheI 
oSE20 FtsI-Fwd ATGGTACCATGAGCGAAGCCTCCCGGGATC KpnI 
oSE21 FtsI-Rev ATGAGCTCTCAAAGTTCGCTCCTGTTCTGGG SacI 
oSE88 FtsIflankingup-fwd AATTAAAAGCTTGCAGAGCGCATATTGAAGCCCGGC HindIII 
oSE89 FtsIflankingup-rev CTTGCTCACCATCTGGGCGCCTCCGCAGG - 
oSE90 VenusftsI'-fwd GGCGCCCAGATGGTGAGCAAGGGCGAGGAGCTG - 
oSE91 VenusftsI'-rev ATGGATCCAGGCGTATCGCTGGCGCGGTTGG BamHI 
oSR01 HNE_0402_del1 TAGTAAGCTTGCGATCGAGACGGATGGATTT HindIII 
oSR02 HNE_0402_del2 TATGAATTCCGCGCCAGAGAGAAAGCGGGG EcoRI 
oSR03 HNE_0402_del3 TATGAATTCGCCAATCTGGTGCGCATCGCC EcoRI 
oSR04 HNE_0402_del4 TATAGCTAGCTATCTCCGCTTCAGGGTTTCC NheI 
oSR05 HNE_0445_del1 TAGTAAGCTTAACCTGCAGAACAACTAGACG HindIII 
oSR06 HNE_0445_del2 TATGAATTCCAGCATGAACAGACGGCGCAC EcoRI 
oSR07 HNE_0445_del3 TATGAATTCGTCGATCTCAACCGGGCAGCA EcoRI 
oSR08 HNE_0445_del4 TATAGCTAGCGGCCATCCATGACTGACAGGT NheI 
oSR09 HNE_1025_del1 TAGTAAGCTTTCCAGCAGCACATCAGCGTAG HindIII 
oSR10 HNE_1025_del2 TATGAATTCATGGACTACACCCGCCGTCAG EcoRI 
oSR11 HNE_1025_del3 TATGAATTCGCGAAACGCACGAGACCAGACT EcoRI 
oSR12 HNE_1025_del4 TATAGCTAGCGCGTAGCCCGACTGGATCTGG NheI 
oSR31 HNE_2934_int_rev2 TAGTAAGCTTACCGCGTCGAGGCCATCTGCA HindIII 
oSR32 HNE_2934_int_for3 GAGCCATCAGGGCAGACGACATGGTGAGCAAGGGCGAGGA - 
oSR33 HNE_2934_int_rev4 TCCTCGCCCTTGCTCACCATGTCGTCTGCCCTGATGGCTC - 
oSR70 HNE_3409_int_for1 TAGTAAGCTTCTCGCCCTTCTGCCCGGTAAA HindIII 
oSR71 HNE_3409_int_for3 TGGACGAGCTGTACAAGTAAAACAAAAAGGGCGGCTCTCG - 
oSR72 HNE_3409_int_rev4 CGAGAGCCGCCCTTTTTGTTTTACTTGTACAGCTCGTCCA - 
oSR73 HNE_1814_int_for1 TAGTAAGCTTCGTCGGCTGTGCGCGATGGCGTGC HindIII 
oSR74 HNE_1814_int_rev2 TATAGCTAGCTGGTCTGCGCTCGAACGTGTC NheI 
oSR75 HNE_1814_int_for3 TGGACGAGCTGTACAAGTAAGAGGGTGTTCGCACGTTTAT - 
oSR76 HNE_1814_int_rev4 ATAAACGTGCGAACACCCTCTTACTTGTACAGCTCGTCCA - 
oSR81 HNE_3349_int_for1 TAGTAAGCTTCCGCAGGGGTTTGACTTCAGC HindIII 
oSR82 HNE_3349_int_rev2 TATAGCTAGCCCCTTCCTGGTCTATGCTGTG NheI 
oSR83 HNE_3349_int_for3 TGGACGAGCTGTACAAGTAAGCGCGTATCCGGGGCGGCGC - 
oSR84 HNE_3349_int_rev4 GCGCCGCCCCGGATACGCGCTTACTTGTACAGCTCGTCCA - 
oSR89 HNE_0674_del1 TAGTAAGCTTCCTCTTCAGCCGCTTCCTTCA HindIII 
oSR90 HNE_0674_del2 AAGGATCCCAGCTCGGCGGTATGAGACGG BamHI 
oSR91 HNE_0674_del3 AAGGATCCTGCTCGAACTTGGCTTCCTGA BamHI 
oSR92 HNE_0674_del4 TATAGCTAGCAAAGGGTGTGGCCGCCGTCAG NheI 
oSS271 HNE_0674-rev ATGGTACCTTGGGACGCGAGGCGGAGATCCTG KpnI 
    
1
 Restriction sites are indicated in boldface. 
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